The FDA implemented its Drug Efficacy Study Implementation (DESI) program to study and regulate drugs, including stanozolol, that had been introduced prior to the amendment. Clinically significant drug interactions with stanozolol arise from its effects on coagulation, carbohydrate metabolism, hepatic enzyme activity, and renal electrolyte handling. For prophylaxis of hereditary
